Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Open in Screener

RXST

RxSight Inc

Jan 17 • 04:00PM ET

30.39

Dollar change -0.79
Percentage change -2.53	%

Healthcare • Medical Devices • USA • NASD

Peers: STAA ALGN ICUI EW BSX MDT SYK TFX BAX XRAY

| Held by: VTI IWM VXF IWO VTWO SCHA VHT XHE DFAS DFAC

Index	RUT	P/E	-	EPS (ttm)	-0.82	Insider Own	5.05%	Shs Outstand	40.25M	Perf Week	-9.09%
Market Cap	1.22B	Forward P/E	-	EPS next Y	-0.45	Insider Trans	-3.62%	Shs Float	38.27M	Perf Month	-21.04%
Income	-30.69M	PEG	-	EPS next Q	-0.17	Inst Own	84.49%	Short Float	6.72%	Perf Quarter	-40.01%
Sales	128.29M	P/S	9.55	EPS this Y	48.73%	Inst Trans	2.46%	Short Ratio	3.69	Perf Half Y	-33.99%
Book/sh	6.89	P/B	4.41	EPS next Y	37.70%	ROA	-12.47%	Short Interest	2.57M	Perf Year	-33.28%
Cash/sh	5.88	P/C	5.17	EPS next 5Y	-	ROE	-13.99%	52W Range	26.29 - 66.54	Perf YTD	-11.61%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-10.66%	52W High	-54.33%	Beta	1.19
Dividend TTM	-	Quick Ratio	11.71	Sales past 5Y	201.89%	Gross Margin	68.44%	52W Low	15.60%	ATR (14)	2.06
Dividend Ex-Date	-	Current Ratio	12.67	EPS Y/Y TTM	52.45%	Oper. Margin	-30.46%	RSI (14)	30.11	Volatility	9.59% 5.50%
Employees	374	Debt/Eq	0.04	Sales Y/Y TTM	67.51%	Profit Margin	-23.92%	Recom	1.40	Target Price	54.50
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	54.24%	Payout	-	Rel Volume	0.90	Prev Close	31.18
Sales Surprise	0.71%	EPS Surprise	35.04%	Sales Q/Q	59.08%	Earnings	Nov 07 AMC	Avg Volume	697.09K	Price	30.39
SMA20	-10.43%	SMA50	-24.17%	SMA200	-39.39%	Trades		Volume	627,464	Change	-2.53%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-20-24	Downgrade	Stifel	Buy → Hold	$65 → $40
Dec-11-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$56 → $42
Dec-06-24	Initiated	UBS	Buy	$52
Oct-29-24	Initiated	Jefferies	Buy	$72
Aug-20-24	Reiterated	Needham	Buy	$54 → $66
Aug-06-24	Reiterated	Needham	Buy	$75 → $54
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40
Dec-04-23	Initiated	Morgan Stanley	Overweight	$36
Apr-13-23	Initiated	Oppenheimer	Outperform	$23
Dec-12-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$20 → $14
Apr-08-22	Initiated	Needham	Buy	$18

Show Previous Ratings

Today 07:55AM	RxSight price target lowered to $43 from $66 at Needham (TipRanks)
Jan-12-25 09:30AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance (GlobeNewswire)
Jan-02-25 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-24 09:43AM	Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? (Insider Monkey) -11.86%
Nov-20-24 12:00PM	RxSight (RXST) Upgraded to Buy: Here's What You Should Know (Zacks)
12:02PM	Loading…
Nov-08-24 12:02PM	RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... (GuruFocus.com) -5.59%
Nov-07-24 07:00PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 (Zacks) -7.09%
04:05PM	RxSight, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:16AM	What To Expect From RxSight Inc (RXST) Q3 2024 Earnings (GuruFocus.com) +5.80%
Oct-24-24 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 (GlobeNewswire)
Oct-15-24 06:10PM	RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds (Insider Monkey)
Oct-13-24 05:33PM	RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now (Insider Monkey)
Aug-22-24 04:05PM	RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences (GlobeNewswire)
Aug-19-24 03:43PM	RxSight Stock Sees Relative Strength Rating Rise To 91 (Investor's Business Daily)
Aug-12-24 09:55AM	Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect? (Zacks)
09:55AM	Loading…
Aug-06-24 09:55AM	Q2 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace)
Jul-29-24 09:35AM	Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround (Zacks)
Jul-22-24 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 (GlobeNewswire)
Jul-12-24 09:35AM	RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jul-10-24 10:59AM	Dow Flat As Nasdaq, S&P 500 Rise Again; Gold Stocks Rally, But These Growth Players Get Hit (Live Coverage) (Investor's Business Daily) -10.32%
Jun-18-24 01:50AM	Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST) (GuruFocus.com)
Jun-13-24 11:22AM	Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock (Investor's Business Daily)
Jun-07-24 02:40PM	These 5 Companies Lost Money. Here's Why They're Still On The IBD 50. (Investor's Business Daily)
Jun-05-24 04:05PM	RxSight, Inc. To Participate in the Truist Securities Medtech Conference (GlobeNewswire)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-28-24 12:00PM	What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now? (Zacks)
May-24-24 11:40AM	Why Top-Rated Medtech RxSight Has 20/20 Vision And Is Seeing 50% Growth (Investor's Business Daily)
04:58PM	Loading…
May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-07-24 12:17PM	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating (MT Newswires)
08:50AM	RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:49AM	Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating (MT Newswires)
08:48AM	Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating (MT Newswires)
08:28AM	BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating (MT Newswires)
06:42AM	Q1 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
04:26AM	RxSight Q1 Adjusted Loss Narrows, Revenue Rises (MT Newswires)
03:10AM	RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-24 05:37PM	RxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
05:06PM	Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing (MT Newswires)
04:05PM	RxSight, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 05:03PM	Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing (MT Newswires) +5.17%
May-01-24 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) +8.77%
Apr-22-24 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 (GlobeNewswire)
Apr-04-24 04:05PM	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens , the LAL+ , and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting (GlobeNewswire) +6.08%
Mar-27-24 04:05PM	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-29-24 07:05PM	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference (GlobeNewswire)
11:09AM	RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:36AM	Q4 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 04:38PM	RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-14-24 04:05PM	RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Jan-19-24 05:01PM	Director Shweta Maniar Sells 6,399 Shares of RxSight Inc (GuruFocus.com)
Jan-12-24 03:16PM	3 Stocks to Buy BEFORE They Become Household Names (InvestorPlace)
Jan-09-24 06:19PM	RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average (Zacks)
Jan-07-24 10:00AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance (GlobeNewswire)
Dec-27-23 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-15-23 09:30AM	RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Nov-12-23 10:26AM	RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 07:42AM	Q3 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +6.22%
Nov-09-23 04:05PM	RxSight, Inc. Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 09:00AM	RxSight, Inc. Educational and Product Announcements for AAO 2023 (GlobeNewswire)
Oct-26-23 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) -5.43%
Sep-07-23 09:35AM	RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
Aug-23-23 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-22-23 05:20PM	Has Alcon (ALC) Outpaced Other Medical Stocks This Year? (Zacks)
Aug-18-23 09:23AM	The Zacks Analyst Blog Highlights Abcam, Integer Holdings and RxSight (Zacks)
Aug-17-23 08:37AM	3 Medical Device Stocks With Potential to Fight Deflation Risk (Zacks)
Aug-08-23 08:44AM	RxSight, Inc. (NASDAQ:RXST) Q2 2023 Earnings Call Transcript (Insider Monkey)
06:21AM	Q2 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-25-23 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023 (GlobeNewswire)
Jun-30-23 08:31AM	Strength Seen in RxSight, Inc. (RXST): Can Its 9.6% Jump Turn into More Strength? (Zacks)
Jun-27-23 08:38AM	Alphatec (ATEC) Surges 8.8%: Is This an Indication of Further Gains? (Zacks)
Jun-18-23 10:53AM	Investors in RxSight (NASDAQ:RXST) have seen respectable returns of 79% over the past year (Simply Wall St.)
May-10-23 07:52AM	Q1 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +9.87%
May-09-23 06:15PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-03-23 10:00AM	Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
May-02-23 10:02AM	Will RxSight, Inc. (RXST) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-26-23 06:33PM	2 Strong Buy Stocks Oppenheimer Predicts Will Surge at Least 30% (TipRanks)
04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
Apr-25-23 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023 (GlobeNewswire)
Apr-24-23 04:05PM	Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting (GlobeNewswire)
Apr-18-23 11:26AM	RxSight, Inc. (NASDAQ:RXST) Not Lagging Industry On Growth Or Pricing (Simply Wall St.)
Apr-11-23 12:00PM	Here's Why RxSight, Inc. (RXST) is a Great Momentum Stock to Buy (Zacks)
Apr-05-23 04:05PM	RxSight, Inc. to Present at the Needham Healthcare Conference (GlobeNewswire)
Mar-13-23 09:55AM	How Much Upside is Left in RxSight, Inc. (RXST)? Wall Street Analysts Think 25.69% (Zacks)
Mar-08-23 07:21AM	RxSight, Inc. (NASDAQ:RXST) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 08:23AM	Q4 2022 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
05:16AM	RxSight, Inc.'s (NASDAQ:RXST) biggest owners are individual investors who got richer after stock soared 14% last week (Simply Wall St.)
Mar-06-23 04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +12.96%
Feb-28-23 04:05PM	RxSight, Inc. to Present at the Oppenheimer Healthcare Conference (GlobeNewswire)
Feb-21-23 04:05PM	RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023 (GlobeNewswire)
Feb-14-23 04:05PM	RxSight, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock (GlobeNewswire)

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Corley Jesse Anderson	Director	Jan 16 '25	Buy	31.13	1,767	55,004	3,210	Jan 17 07:08 PM
Corley Jesse Anderson	Director	Jan 15 '25	Buy	31.18	1,443	45,000	1,443	Jan 17 07:08 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Option Exercise	15.08	3,105	46,823	45,351	Dec 03 06:38 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Sale	46.08	3,105	143,078	42,246	Dec 03 06:38 PM
ILYA GOLDSHLEGER	Officer	Nov 29 '24	Proposed Sale	46.08	3,105	143,078		Nov 29 01:29 PM
Maniar Shweta	Director	Nov 26 '24	Sale	45.88	3,782	173,518	10,902	Nov 26 07:26 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Sale	45.88	3,100	142,228	42,246	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Sale	45.00	3,100	139,500	42,246	Nov 26 07:25 PM
ILYA GOLDSHLEGER	Officer	Nov 26 '24	Proposed Sale	45.88	3,100	142,228		Nov 26 04:13 PM
Maniar Shweta	Director	Nov 26 '24	Proposed Sale	45.88	3,782	173,518		Nov 26 02:45 PM
ILYA GOLDSHLEGER	Officer	Nov 22 '24	Proposed Sale	45.00	3,100	139,500		Nov 22 04:15 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Option Exercise	15.08	4,875	73,515	47,121	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Sale	46.00	4,875	224,250	42,246	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Sale	45.00	3,100	139,502	42,246	Nov 18 09:50 PM
ILYA GOLDSHLEGER	Officer	Nov 18 '24	Proposed Sale	45.00	3,100	139,502		Nov 18 04:29 PM
ILYA GOLDSHLEGER	Officer	Nov 15 '24	Proposed Sale	46.00	4,875	224,250		Nov 15 04:18 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Option Exercise	15.08	1,330	20,056	43,576	Nov 14 07:42 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Sale	46.13	1,330	61,356	42,246	Nov 14 07:42 PM
Corley Jesse Anderson	Director	Nov 12 '24	Buy	45.37	11,111	504,079	468,571	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	44.84	5,795	259,841	38,438	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	45.00	5,570	250,650	474,141	Nov 14 07:14 PM
ILYA GOLDSHLEGER	Officer	Nov 12 '24	Proposed Sale	46.13	1,330	61,356		Nov 12 05:38 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 08 04:00 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Sale	55.00	3,100	170,495	42,246	Nov 08 04:00 PM
ILYA GOLDSHLEGER	Officer	Nov 07 '24	Proposed Sale	55.00	3,100	170,494		Nov 07 04:14 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 05 04:05 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Sale	51.05	3,100	158,247	42,246	Nov 05 04:05 PM
ILYA GOLDSHLEGER	Officer	Nov 04 '24	Proposed Sale	51.05	3,100	158,247		Nov 04 04:17 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 31 05:22 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Sale	51.91	3,105	161,171	42,246	Oct 31 05:22 PM
LYA GOLDSHLEGER	Officer	Oct 30 '24	Proposed Sale	51.91	3,105	161,171		Oct 30 04:28 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Sale	50.64	3,100	156,993	42,246	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Sale	49.79	3,100	154,360	42,246	Oct 28 08:55 PM
ILYA GOLDSHLEGER	Officer	Oct 28 '24	Proposed Sale	50.64	3,100	156,993		Oct 28 04:15 PM
ILYA GOLDSHLEGER	Officer	Oct 25 '24	Proposed Sale	49.79	3,100	154,360		Oct 25 04:15 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 22 08:17 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Sale	49.68	3,100	154,001	42,246	Oct 22 08:17 PM
ILYA GOLDSHLEGER	Officer	Oct 22 '24	Proposed Sale	49.68	3,100	154,001		Oct 22 04:16 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Sale	50.09	3,105	155,533	42,246	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Sale	49.78	3,100	154,318	42,246	Oct 18 05:23 PM
ILYA GOLDSHLEGER	Officer	Oct 18 '24	Proposed Sale	50.09	3,105	155,533		Oct 18 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 16 '24	Proposed Sale	49.78	3,100	154,317		Oct 16 04:16 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Sale	50.19	3,100	155,594	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Sale	50.09	3,100	155,268	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Sale	48.82	3,105	151,596	42,246	Oct 15 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 14 '24	Proposed Sale	50.09	3,100	155,268		Oct 15 08:23 AM
ILYA GOLDSHLEGER	Officer	Oct 11 '24	Proposed Sale	50.19	3,100	155,593		Oct 11 04:17 PM
ILYA GOLDSHLEGER	Officer	Oct 10 '24	Proposed Sale	48.82	3,105	151,595		Oct 10 04:11 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Sale	48.26	3,100	149,612	42,246	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Sale	48.01	3,100	148,824	42,246	Oct 08 06:00 PM
ILYA GOLDSHLEGER	Officer	Oct 08 '24	Proposed Sale	48.26	3,100	149,612		Oct 08 04:19 PM
ILYA GOLDSHLEGER	Officer	Oct 04 '24	Proposed Sale	48.01	3,100	148,824		Oct 04 04:23 PM
Thunen Shelley B	See remarks	Oct 01 '24	Option Exercise	16.00	15,000	240,000	45,443	Oct 02 04:11 PM
Thunen Shelley B	See remarks	Oct 01 '24	Sale	48.45	15,000	726,730	30,443	Oct 02 04:11 PM
SHELLEY B THUNEN	Officer	Oct 01 '24	Proposed Sale	48.45	15,000	726,729		Oct 01 04:24 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Option Exercise	15.08	3,105	46,823	45,351	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Sale	49.29	3,105	153,054	42,246	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Sale	49.02	3,100	151,947	42,246	Sep 30 08:05 PM
ILYA GOLDSHLEGER	Officer	Sep 30 '24	Proposed Sale	49.02	3,100	151,946		Sep 30 04:14 PM
ILYA GOLDSHLEGER	Officer	Sep 26 '24	Proposed Sale	49.29	3,105	153,054		Sep 26 04:09 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Sale	53.19	3,100	164,901	42,246	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Sale	52.67	3,100	163,263	42,246	Sep 23 06:48 PM
ILYA GOLDSHLEGER	Officer	Sep 23 '24	Proposed Sale	52.67	3,100	163,263		Sep 23 04:08 PM
ILYA GOLDSHLEGER	Officer	Sep 20 '24	Proposed Sale	53.19	3,100	164,901		Sep 20 04:08 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 18 04:41 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Sale	56.11	3,100	173,944	42,246	Sep 18 04:41 PM
ILYA GOLDSHLEGER	Officer	Sep 17 '24	Proposed Sale	56.11	3,100	173,943		Sep 17 04:15 PM
Kurtz Ronald M MD	President & CEO	Aug 09 '24	Option Exercise	12.60	9,950	125,355	63,450	Aug 09 05:57 PM
Goldshleger Ilya	See remarks	Aug 05 '24	Sale	39.25	9,000	353,291	42,246	Aug 06 04:19 PM
ILYA GOLDSHLEGER	Officer	Aug 05 '24	Proposed Sale	39.25	9,000	353,290		Aug 05 04:08 PM
Thunen Shelley B	See remarks	Jul 15 '24	Option Exercise	4.34	16,505	71,632	30,443	Jul 16 08:15 PM
Kurtz Ronald M MD	President & CEO	Jul 11 '24	Option Exercise	15.08	13,500	203,604	53,500	Jul 12 07:12 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Option Exercise	15.60	10,000	155,983	23,938	Jul 02 04:25 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Sale	58.61	10,000	586,055	13,938	Jul 02 04:25 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Sale	58.77	8,402	493,760	0	Jul 02 04:25 PM
Andrews Julie	Director	Jun 14 '24	Sale	58.00	15,625	906,288	30,287	Jun 17 06:45 PM
Tammenoms Bakker Juliet	Director	May 17 '24	Buy	61.09	5,000	305,456	34,840	May 21 04:11 PM
Goldshleger Ilya	Chief Operating Officer	May 17 '24	Option Exercise	4.04	24,771	100,066	51,246	May 20 04:56 PM
Kurtz Ronald M MD	President & CEO	May 03 '24	Sale	60.15	40,000	2,405,872	764,610	May 06 05:02 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Option Exercise	15.60	10,247	159,836	23,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Sale	52.69	10,000	526,913	13,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	Apr 01 '24	Sale	49.90	20,000	997,946	8,402	Apr 02 04:18 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Option Exercise	15.60	10,000	155,983	23,691	Mar 05 04:05 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Sale	56.37	10,000	563,726	13,691	Mar 05 04:05 PM
Goldshleger Ilya	Chief Operating Officer	Feb 15 '24	Option Exercise	23.04	10,000	230,400	36,475	Feb 16 05:00 PM

Open in Screener

OFIX

Orthofix Medical Inc

Jan 17 • 04:00PM ET

18.13

Dollar change +0.20
Percentage change 1.12	%

Healthcare • Medical Devices • USA • NASD

OFIX Orthofix Medical Inc daily Stock Chart

Peers: JNJ MDT SYK BSX GMED ZBH ATEC IART CNMD NUVB

| Held by: VTI IWM VXF IWN IHI SCHA VTWO VHT DFAT IWC

Index	RUT	P/E	-	EPS (ttm)	-3.14	Insider Own	3.59%	Shs Outstand	38.21M	Perf Week	6.65%
Market Cap	692.82M	Forward P/E	-	EPS next Y	-0.91	Insider Trans	-1.46%	Shs Float	36.84M	Perf Month	0.67%
Income	-119.03M	PEG	-	EPS next Q	-0.27	Inst Own	94.23%	Short Float	2.94%	Perf Quarter	13.17%
Sales	784.25M	P/S	0.88	EPS this Y	31.88%	Inst Trans	7.35%	Short Ratio	4.13	Perf Half Y	16.67%
Book/sh	13.76	P/B	1.32	EPS next Y	67.67%	ROA	-13.42%	Short Interest	1.08M	Perf Year	36.32%
Cash/sh	0.85	P/C	21.28	EPS next 5Y	-	ROE	-20.86%	52W Range	12.08 - 20.73	Perf YTD	3.84%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-17.73%	52W High	-12.54%	Beta	1.10
Dividend TTM	-	Quick Ratio	1.11	Sales past 5Y	15.97%	Gross Margin	65.83%	52W Low	50.08%	ATR (14)	0.57
Dividend Ex-Date	-	Current Ratio	2.39	EPS Y/Y TTM	19.53%	Oper. Margin	-10.91%	RSI (14)	58.09	Volatility	2.63% 3.42%
Employees	1634	Debt/Eq	0.30	Sales Y/Y TTM	17.32%	Profit Margin	-15.18%	Recom	1.80	Target Price	24.40
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	8.15%	Payout	-	Rel Volume	0.38	Prev Close	17.93
Sales Surprise	0.04%	EPS Surprise	-105.80%	Sales Q/Q	6.85%	Earnings	Nov 07 BMO	Avg Volume	261.94K	Price	18.13
SMA20	3.82%	SMA50	-0.28%	SMA200	14.53%	Trades		Volume	100,364	Change	1.12%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-08-24	Upgrade	Stifel	Hold → Buy	$18 → $24
May-08-24	Upgrade	ROTH MKM	Neutral → Buy	$15 → $20
Oct-20-23	Initiated	ROTH MKM	Neutral	$12
Sep-12-23	Downgrade	Stifel	Buy → Hold
Sep-12-23	Downgrade	BTIG Research	Buy → Neutral
Jul-19-23	Resumed	BTIG Research	Buy	$27
Mar-04-22	Upgrade	Stifel	Hold → Buy	$41 → $45
Oct-20-20	Initiated	Stifel	Hold	$39
Oct-29-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$71 → $48
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
Jun-21-17	Initiated	BTIG Research	Buy	$52
Jun-14-17	Initiated	Ladenburg Thalmann	Buy	$53.25
May-23-17	Initiated	SunTrust	Buy	$49
Jul-10-15	Initiated	Sidoti	Buy
May-09-13	Downgrade	Mizuho	Buy → Neutral	$45 → $28
Jan-08-13	Reiterated	Mizuho	Buy	$47 → $45
Jun-21-10	Initiated	Boenning & Scattergood	Outperform	$45
Mar-09-10	Reiterated	Jefferies & Co	Buy	$38 → $40
Feb-18-10	Upgrade	Susquehanna Financial	Neutral → Positive
Jan-22-10	Initiated	Jefferies & Co	Buy	$37

Show Previous Ratings

Nov-12-24 07:05AM	Orthofix to Participate in Upcoming Investor Conferences (Business Wire)
Nov-08-24 07:32AM	Orthofix Reports Q3 Sales Growth and New Financial Targets (TipRanks) +6.53%
02:14AM	Orthofix Medical Inc (OFIX) Q3 2024 Earnings Call Highlights: Strong Growth in US Spine ... (GuruFocus.com)
Nov-07-24 08:25AM	Orthofix (OFIX) Q3 Earnings Surpass Estimates (Zacks)
07:23AM	Orthofix: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Loading…
07:05AM	Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets (Business Wire)
07:05AM	Orthofix Announces New Term Loan (Business Wire)
Nov-06-24 07:30AM	What To Expect From Orthofix Medical Inc (OFIX) Q3 2024 Earnings (GuruFocus.com)
Oct-21-24 07:00AM	Orthofix to Participate in Stifel 2024 Healthcare Conference (Business Wire)
Oct-10-24 07:00AM	Orthofix to Report Third Quarter 2024 Financial Results (Business Wire)
Oct-09-24 12:34PM	Shareholders of Orthofix Medical Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights OFIX (GlobeNewswire)
Sep-27-24 05:45AM	Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - OFIX (PR Newswire)
Sep-23-24 07:00AM	Orthofix Highlights New Products and Announces Presentation of Data Supporting the Adjunct Use of Bone Growth Therapy for Lumbar Spine Fusion at North American Spine Society Annual Meeting (Business Wire)
Sep-13-24 05:45AM	Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - OFIX (PR Newswire)
Aug-30-24 10:22AM	Orthofix Medical Inc (NASDAQ:OFIX) A Bull Case Theory (Insider Monkey)
05:52PM	Loading…
Aug-15-24 05:52PM	Patrick Fisher Joins Orthofix as President of Global Orthopedics Business (Business Wire)
Aug-07-24 06:09AM	Q2 2024 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-06-24 08:15AM	Orthofix (OFIX) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +19.53%
07:17AM	Orthofix: Q2 Earnings Snapshot (Associated Press Finance)
07:03AM	Orthofix Reports Second Quarter 2024 Results and Raises Full-Year 2024 Financial Guidance (Business Wire)
Jul-17-24 07:00AM	Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference (Business Wire)
Jul-16-24 07:00AM	Orthofix Names Stephanie Walsh Chief Human Resources Officer (Business Wire)
Jul-10-24 12:13PM	Orthofix Medical's (OFIX) Fitbone System Gets FDA Clearance (Zacks)
06:32AM	Orthofix obtains FDA clearance for Fitbone system (Medical Device Network)
Jul-09-24 07:00AM	Orthofix to Report Second Quarter 2024 Financial Results (Business Wire)
07:00AM	Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System (Business Wire)
Jun-24-24 07:00AM	Michael Finegan Named Chair of the Orthofix Board of Directors (Business Wire)
03:11AM	Orthofixs president of global orthopedics resigns (MedTech Dive)
Jun-18-24 07:00AM	Aviva McPherron Joins Orthofix as President of Global Operations and Quality (Business Wire)
Jun-11-24 07:00AM	Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine (Business Wire)
07:00AM	Loading…
May-23-24 07:00AM	Orthofix Names Max Reinhardt President of Global Spine Business (Business Wire)
May-16-24 07:15AM	Orthofix Wins Best Patient Experience Solution Award in 2024 MedTech Breakthrough Awards Program (GlobeNewswire)
May-13-24 11:18AM	Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance (Zacks)
May-09-24 07:00AM	Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail (Business Wire)
May-08-24 01:03PM	Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript (Insider Monkey) +7.27%
07:43AM	Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target (MT Newswires)
03:16AM	Orthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
May-07-24 10:38PM	Q1 2024 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents)
01:53PM	OFIX Stock Earnings: Orthofix Medical Meets EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:34AM	Orthofix Medical Inc. (OFIX) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Net Loss Widening (GuruFocus.com)
08:21AM	Orthofix: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Orthofix Reports First Quarter 2024 Results (Business Wire)
Apr-26-24 06:37AM	Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors (Barrons.com)
Apr-23-24 07:00AM	Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 (Business Wire)
Apr-16-24 07:00AM	Orthofix Names Andres Cedron as New Chief Legal Officer (Business Wire)
Mar-18-24 07:00AM	Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer (Business Wire)
Mar-12-24 11:01AM	Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Up (Zacks)
Mar-07-24 01:40PM	Orthofix Medical Inc (OFIX) Reports Significant Sales Growth and Improved EBITDA in Q4 and Full ... (GuruFocus.com)
09:53AM	Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 08:21AM	Q4 2023 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents) +8.69%
Mar-05-24 10:52PM	OFIX Stock Earnings: Orthofix Medical Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:42PM	Orthofix: Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Orthofix Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-29-24 07:00AM	Orthofix Announces New President for Bone Growth Therapies Business (Business Wire)
Feb-21-24 07:00AM	Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024 (Business Wire)
Jan-18-24 07:00AM	Orthofix Announces Commercial Partnership with MRIguidance (Business Wire)
Jan-16-24 07:00AM	Julie Andrews Begins as New Chief Financial Officer at Orthofix (Business Wire)
Jan-09-24 08:00AM	Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results (Business Wire) +9.78%
Jan-08-24 07:00AM	Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer (Business Wire)
Dec-27-23 08:45AM	Orthofix (OFIX) Releases New Data for Spinal Fusion Procedures (Zacks)
Dec-21-23 07:00AM	Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis (Business Wire)
Dec-12-23 07:00AM	Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company (Business Wire)
Dec-11-23 09:55AM	Wall Street Analysts Believe Orthofix (OFIX) Could Rally 72.19%: Here's is How to Trade (Zacks)
Dec-01-23 06:16PM	Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Nov-29-23 12:21PM	Lowey Dannenberg, P.C. is Investigating Orthofix Medical Inc. (NASDAQ: OFIX) for Potential Breaches of Fiduciary Duty by Its Board of Directors (GlobeNewswire)
07:00AM	Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc (Business Wire)
Nov-28-23 11:30AM	Orthofix hires new CEO, 2 months after former leaders ousted (MedTech Dive)
07:00AM	Orthofix Names Massimo Calafiore as President and Chief Executive Officer (Business Wire)
Nov-27-23 10:48AM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management (GlobeNewswire)
Nov-24-23 12:28PM	Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut (Zacks)
Nov-23-23 09:55AM	Does Orthofix (OFIX) Have the Potential to Rally 78.73% as Wall Street Analysts Expect? (Zacks)
Nov-21-23 06:30PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management (GlobeNewswire)
Nov-13-23 09:00AM	ORTHOFIX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options (PR Newswire)
Nov-09-23 01:43PM	Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call Transcript (Insider Monkey) -10.37%
Nov-08-23 05:36PM	Orthofix: Q3 Earnings Snapshot (Associated Press Finance)
04:07PM	Orthofix Reports Third Quarter 2023 Results (Business Wire)
09:00AM	ORTHOFIX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options (PR Newswire)
Nov-07-23 03:59PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management (GlobeNewswire)
Nov-06-23 07:00AM	Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures (Business Wire)
Nov-02-23 10:00AM	Hologic (HOLX) Earnings Expected to Grow: Should You Buy? (Zacks) +5.98%
Nov-01-23 10:01AM	Orthofix (OFIX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-31-23 01:48PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-29-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, Dollar, and Clorox and Encourages Investors to Contact the Firm (GlobeNewswire)
Oct-23-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Viasat, Veradigm, and Orthofix and Encourages Investors to Contact the Firm (GlobeNewswire)
03:54PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-18-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm (GlobeNewswire) -6.66%
07:00AM	Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023 (Business Wire)
Oct-17-23 08:33AM	Orthofix (OFIX) Secures FDA 510k Clearance for OsteoCove Graft (Zacks)
Oct-13-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm (GlobeNewswire)
08:40PM	Orthofix Medical Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
08:23AM	Orthofix (OFIX) Soars 6.4%: Is Further Upside Left in the Stock? (Zacks)
Oct-12-23 09:10AM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Orthofix Medical Inc. (PR Newswire) +6.41%
07:00AM	Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures (Business Wire)
Oct-09-23 05:25PM	Orthofix Medical Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
01:48PM	Hagens Berman Encourages Orthofix Medical (OFIX) Shareholders to Contact the Firm (GlobeNewswire)
Oct-08-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm (GlobeNewswire)
Oct-06-23 09:13AM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Orthofix Medical Inc. (PR Newswire)
Oct-02-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm (GlobeNewswire)
Sep-27-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating FMC, and Orthofix and Encourages Investors to Contact the Firm (GlobeNewswire)
Sep-21-23 09:22AM	Orthofix (OFIX) Unveils Gemini System, Advances in Trauma Wing (Zacks)

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Calafiore Massimo	President & CEO	Jan 10 '25	Sale	16.83	10,078	169,619	133,354	Jan 14 04:27 PM
Calafiore Massimo	President & CEO	Jan 13 '25	Sale	17.14	9,203	157,757	124,151	Jan 14 04:27 PM
Gillespie Geoffrey C	CAO	Jan 10 '25	Sale	16.83	248	4,174	40,317	Jan 14 04:27 PM
Gillespie Geoffrey C	CAO	Jan 13 '25	Sale	17.14	227	3,891	40,090	Jan 14 04:27 PM
Gillespie Geoffrey C	CAO	Jan 07 '25	Sale	17.14	238	4,078	40,803	Jan 10 04:24 PM
Gillespie Geoffrey C	CAO	Jan 08 '25	Sale	16.97	238	4,039	40,565	Jan 10 04:24 PM
Gillespie Geoffrey C	CAO	Dec 17 '24	Sale	17.84	26	464	41,041	Dec 19 04:19 PM

RXST

RxSight Inc

OFIX

Orthofix Medical Inc

Upgrade your FINVIZ experience